Kristine Burke

3.7k total citations
17 papers, 1.1k citations indexed

About

Kristine Burke is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Kristine Burke has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Cell Biology. Recurrent topics in Kristine Burke's work include Protein Degradation and Inhibitors (5 papers), Microtubule and mitosis dynamics (4 papers) and Ubiquitin and proteasome pathways (4 papers). Kristine Burke is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Microtubule and mitosis dynamics (4 papers) and Ubiquitin and proteasome pathways (4 papers). Kristine Burke collaborates with scholars based in United States, Switzerland and Japan. Kristine Burke's co-authors include Xuling Zhu, Paolo G.V. Martini, Eric R. Fedyk, Lili Yang, Vivek J. Kadambi, Hua Yang, Tim Wyant, Vilmos Csizmadia, Summar Siddiqui and Vaishali Shinde and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Kristine Burke

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristine Burke United States	11	749	276	243	225	130	17	1.1k
Sorin Armeanu Germany	19	880 1.2×	403 1.5×	227 0.9×	289 1.3×	136 1.0×	38	1.4k
Sima J. Zacharek United States	13	821 1.1×	387 1.4×	161 0.7×	320 1.4×	48 0.4×	16	1.2k
Anna Morena D’Alise Italy	19	866 1.2×	592 2.1×	349 1.4×	464 2.1×	134 1.0×	42	1.7k
Matthew W. VanBrocklin United States	15	617 0.8×	190 0.7×	270 1.1×	275 1.2×	105 0.8×	32	1.1k
Maria C. Speranza United States	12	463 0.6×	200 0.7×	427 1.8×	460 2.0×	95 0.7×	21	982
Anthony Cruz United States	14	695 0.9×	579 2.1×	98 0.4×	269 1.2×	79 0.6×	21	1.1k
Patricia M. Rosten Canada	14	915 1.2×	387 1.4×	168 0.7×	247 1.1×	31 0.2×	17	1.4k
Francesca R. Santoni de Sio Italy	17	606 0.8×	266 1.0×	408 1.7×	176 0.8×	99 0.8×	26	976
Konrad Miatkowski United States	13	1.0k 1.4×	529 1.9×	191 0.8×	192 0.9×	85 0.7×	16	1.6k
Baisong Mei United States	15	704 0.9×	103 0.4×	160 0.7×	94 0.4×	130 1.0×	44	1.4k

Countries citing papers authored by Kristine Burke

Since Specialization

Citations

This map shows the geographic impact of Kristine Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristine Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristine Burke more than expected).

Fields of papers citing papers by Kristine Burke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristine Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristine Burke. The network helps show where Kristine Burke may publish in the future.

Co-authorship network of co-authors of Kristine Burke

This figure shows the co-authorship network connecting the top 25 collaborators of Kristine Burke. A scholar is included among the top collaborators of Kristine Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristine Burke. Kristine Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hassett, Kimberly J., et al.. (2023). mRNA vaccine trafficking and resulting protein expression after intramuscular administration. Molecular Therapy — Nucleic Acids. 35(1). 102083–102083. 51 indexed citations

Liu, Xiao-Bo, Kristine Burke, Xuling Zhu, et al.. (2022). Intermittent lipid nanoparticle mRNA administration prevents cortical dysmyelination associated with arginase deficiency. Molecular Therapy — Nucleic Acids. 28. 859–874. 16 indexed citations

Hewitt, Susannah L., Ailin Bai, D. R. Shackleton Bailey, et al.. (2019). Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs. Science Translational Medicine. 11(477). 223 indexed citations

Zhu, Xuling, Ling Yin, Summar Siddiqui, et al.. (2019). Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates. The American Journal of Human Genetics. 104(4). 625–637. 122 indexed citations

Allegri, Gabriella, Xiaobo Liu, Kristine Burke, et al.. (2019). Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency. Proceedings of the National Academy of Sciences. 116(42). 21150–21159. 110 indexed citations

Besin, Gilles, Jaclyn Milton, Staci Sabnis, et al.. (2019). Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocytes to Distinct Antigenic Moieties. ImmunoHorizons. 3(7). 282–293. 80 indexed citations

Jain, Ruchi, Eric Yi‐Hsiu Huang, Kristine Burke, et al.. (2018). MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct. Nucleic Acid Therapeutics. 28(5). 285–296. 111 indexed citations

Sarantopoulos, John, Geoffrey I. Shapiro, Roger B. Cohen, et al.. (2015). Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors. Clinical Cancer Research. 22(4). 847–857. 139 indexed citations

Bahamón, Brittany, Feng Gao, B. M. J. Stringer, et al.. (2014). 231 Clinical pharmacodynamic assay development for the first in class investigational ubiquitin activating enzyme (UAE) inhibitor MLN7243. European Journal of Cancer. 50. 78–78. 1 indexed citations

10.

Shinde, Vaishali, Kristine Burke, Arijit Chakravarty, et al.. (2013). Applications of Pathology-Assisted Image Analysis of Immunohistochemistry-Based Biomarkers in Oncology. Veterinary Pathology. 51(1). 292–303. 16 indexed citations

11.

Fedyk, Eric R., Tim Wyant, Lili Yang, et al.. (2012). Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates. Inflammatory Bowel Diseases. 18(11). 2107–2119. 114 indexed citations

12.

McDonald, Alice, Kristine Burke, Michaël Thomas, et al.. (2011). Abstract A38: Development and implementation of immunohistochemistry (IHC)-based pharmacodynamic (PD) biomarkers demonstrate NAE pathway inhibition in MLN4924 solid tumor clinical trials.. Molecular Cancer Therapeutics. 10(11_Supplement). A38–A38. 1 indexed citations

13.

Donelan, Jill, Bret Bannerman, Paul Hales, et al.. (2009). Antitumor Activity of MLN9708, a Second-Generation Proteasome Inhibitor, in Preclinical Models of Lymphoma.. Blood. 114(22). 3724–3724. 1 indexed citations

14.

Huck, Jessica J., Arijit Chakravarty, Yu Li, et al.. (2007). Preclinical PK/PD/Efficacy relationship of MLN8054, a small molecule Aurora A kinase inhibitor. Molecular Cancer Therapeutics. 6. 2 indexed citations

15.

Leroy, Patrick, John Hunter, Kara M. Hoar, et al.. (2007). Localization of Human TACC3 to Mitotic Spindles Is Mediated by Phosphorylation on Ser558 by Aurora A: A Novel Pharmacodynamic Method for Measuring Aurora A Activity. Cancer Research. 67(11). 5362–5370. 100 indexed citations

16.

Galvin, Katherine, Jessica J. Huck, Olga Burenkova, et al.. (2006). Preclinical pharmacodynamic studies of Aurora A inhibition by MLN8054. Journal of Clinical Oncology. 24(18_suppl). 13059–13059. 9 indexed citations

17.

Liu, Fang, J. Gonzalo, Stephen Manning, et al.. (2005). Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). Prostaglandins & Other Lipid Mediators. 76(1-4). 133–147. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact